[Lactitol in the treatment of constipation in the adult. Open, non-comparative study of its efficacy and its clinical and biological tolerance].
To study clinical and biological tolerability, 114 chronically constipated patients of both sexes, aged 18-70, without any organic alteration of the colon, received lactitol over a period of one or two months. Clinical tolerability was found to be good by 80 per cent of patients and biological tolerability excellent. Clinical efficacy was found correct for 80 per cent of patients with a dosage of 20 g (single dose in the evening). All patients, except one, agreed with the packaging and the taste of the product.
Delas
N
N
CHI, Montfermeil.
Gislon
J
J
Glikmanas
M
M
Henri-Biabaud
E
E
Lemerez
M
M
Licht
H
H
Slama
J L
JL
Gillaume
P N
PN
D000293:Adolescent; D000328:Adult; D000368:Aged; D003248:Constipation / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D013402:Sugar Alcohols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D013402:Sugar Alcohols; C014635:lactitol
Le lactitol dans le traitement de la constipation de l'adulte. Etude ouverte, non comparative de son efficacité et de sa tolérance clinique et biologique.